Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (RIG2) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€52.44 Billion ≈ $61.30 Billion USD) by net assets (€1.30 Trillion ≈ $1.52 Trillion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Richter Gedeon Vegyészeti Gyár Nyilvános defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Galaxy Digital Holdings Ltd
NASDAQ:GLXY
|
-0.030x |
|
Jiangsu Nata Opto Electr Material
SHE:300346
|
0.058x |
|
Guocheng Mining Co Ltd
SHE:000688
|
0.007x |
|
Hengyi Petrochemical Co Ltd
SHE:000703
|
0.025x |
|
Informatica Inc
NYSE:INFA
|
0.061x |
|
Spring Airlines Co Ltd
SHG:601021
|
0.142x |
|
Central Bancompany, Inc. Class A Common Stock
NASDAQ:CBC
|
0.020x |
|
Nkt A/S
NYSE:NRKBY
|
0.025x |
Annual Cash Flow Conversion Efficiency for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt (2013–2025)
The table below shows the annual cash flow conversion efficiency of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see RIG2 market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €1.40 Trillion ≈ $1.64 Trillion |
€276.40 Billion ≈ $323.14 Billion |
0.197x | -7.91% |
| 2024-12-31 | €1.30 Trillion ≈ $1.52 Trillion |
€279.37 Billion ≈ $326.61 Billion |
0.214x | +67.87% |
| 2023-12-31 | €1.14 Trillion ≈ $1.34 Trillion |
€145.84 Billion ≈ $170.50 Billion |
0.128x | -26.81% |
| 2022-12-31 | €1.06 Trillion ≈ $1.24 Trillion |
€184.93 Billion ≈ $216.20 Billion |
0.174x | +15.06% |
| 2021-12-31 | €923.02 Billion ≈ $1.08 Trillion |
€139.90 Billion ≈ $163.56 Billion |
0.152x | -7.60% |
| 2020-12-31 | €813.94 Billion ≈ $951.58 Billion |
€133.52 Billion ≈ $156.10 Billion |
0.164x | +21.07% |
| 2019-12-31 | €724.87 Billion ≈ $847.45 Billion |
€98.21 Billion ≈ $114.82 Billion |
0.135x | -7.41% |
| 2018-12-31 | €685.75 Billion ≈ $801.71 Billion |
€100.34 Billion ≈ $117.31 Billion |
0.146x | +16.02% |
| 2017-12-31 | €664.02 Billion ≈ $776.31 Billion |
€83.75 Billion ≈ $97.91 Billion |
0.126x | +11.08% |
| 2016-12-31 | €681.87 Billion ≈ $797.18 Billion |
€77.42 Billion ≈ $90.51 Billion |
0.114x | -26.13% |
| 2015-12-31 | €618.39 Billion ≈ $722.96 Billion |
€95.05 Billion ≈ $111.12 Billion |
0.154x | +38.81% |
| 2014-12-31 | €561.73 Billion ≈ $656.72 Billion |
€62.20 Billion ≈ $72.72 Billion |
0.111x | -17.46% |
| 2013-12-31 | €551.20 Billion ≈ $644.41 Billion |
€73.94 Billion ≈ $86.45 Billion |
0.134x | -- |
About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. It offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids; and Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chron… Read more